Novavax, Inc.
NVAX
$6.78
$0.182.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.84% | -34.41% | 451.51% | 54.58% | 7.25% |
| Total Depreciation and Amortization | -48.15% | -32.06% | -31.34% | 15.96% | 12.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 752.29% | -104.71% | 54.19% | -238.60% | -54.91% |
| Change in Net Operating Assets | 416.85% | -308.57% | -2,258.47% | 1.91% | -219.07% |
| Cash from Operations | 174.44% | -140.56% | -122.01% | 2.05% | -265.18% |
| Capital Expenditure | -47.01% | 91.41% | 82.26% | 78.14% | 92.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -504.13% | 130.11% | -19,281.45% | -19,441.42% | 14,384.98% |
| Cash from Investing | -527.83% | 129.81% | -911.30% | 1,686.33% | 273.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -92.19% | -67.21% | -511.39% | -18.84% | -129.12% |
| Issuance of Common Stock | 1,174.22% | -- | -- | -- | -99.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 688.96% | -688.96% | -- | -- |
| Cash from Financing | 43,854.64% | -100.40% | -219.96% | -103.41% | -100.05% |
| Foreign Exchange rate Adjustments | -89.08% | 5,167.95% | 68.53% | -467.40% | -35.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.44% | -104.76% | -203.63% | 47.55% | -172.07% |